Aplidin Termina la Fase II del Ensayo en Pacientes con Dedifferentiated Liposarcoma (DLPS) . This study has been terminated.

Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial (APLIPO) .

Recruitment Information :

*.- Status : Terminated .

*.- Start date : 2012-02 .


Administrative Data :

*.- Organization name : Institut Bergonié

*.- Organization study : ID IB2011-02


*.- Sponsor : Institut Bergonié

*.- Collaborator :: Ministry of Health, France

*.- Collaborator : PharmaMar

*.- Health Authority France : Agence Française de Sécurité Sanitaire des Produits de Santé

...